Target Name: ZBTB45P2
NCBI ID: G729248
Review Report on ZBTB45P2 Target / Biomarker Content of Review Report on ZBTB45P2 Target / Biomarker
ZBTB45P2
Other Name(s): zinc finger and BTB domain containing 45 pseudogene 2 | Zinc finger and BTB domain containing 45 pseudogene 2

ZBTB45P2: A Zinc Finger and BTB Domain Containing 45 Pseudogene 2 as a Potential Drug Target

Abstract:

ZBTB45P2, a zinc finger and BTB domain-containing gene, has been identified as a potential drug target and biomarker for various diseases. This gene has 45 pseudogenes, which have not been fully characterized. ZBTB45P2 has been shown to be involved in various cellular processes, including cell adhesion, migration, and invasion. It is also associated with various diseases, including cancer, neurodegenerative diseases, and autoimmune diseases. Therefore, targeting ZBTB45P2 may provide new insights into the pathogenesis and potential therapeutic approaches for these diseases.

Introduction:

Zinc finger genes (ZFGs) and BTB domains are important protein families that have been implicated in various cellular processes. ZFGs are a type of non-coding RNA-binding protein that can interact with specific DNA sequences to regulate gene expression. BTB domains are a type of zinc finger gene that are characterized by the presence of a BTB domain and a variable number of ZFGs. These domains are involved in various cellular processes, including cell adhesion, migration, and invasion.

ZBTB45P2: A Potential Drug Target

ZBTB45P2 is a gene that contains both a ZFG and a BTB domain. It has 45 pseudogenes, which have not been fully characterized. ZBTB45P2 has been shown to be involved in various cellular processes, including cell adhesion, migration, and invasion. It is also associated with various diseases, including cancer, neurodegenerative diseases, and autoimmune diseases. Therefore, targeting ZBTB45P2 may provide new insights into the pathogenesis and potential therapeutic approaches for these diseases.

Disease-Related Processes:

ZBTB45P2 is involved in various cellular processes that are associated with the development and progression of various diseases. One of the most significant functions of ZBTB45P2 is its role in cell adhesion and migration. ZBTB45P2 has been shown to be involved in the regulation of cell-cell adhesion and the migration of cells. This gene has been shown to be involved in the development of various diseases, including cancer, neurodegenerative diseases, and autoimmune diseases.

In addition to its role in cell adhesion and migration, ZBTB45P2 is also involved in the regulation of cell cycle progression. This gene has been shown to be involved in the regulation of cell cycle progression, which is a critical process that is involved in the development and progression of various diseases.

Potential Therapeutic Applications:

Targeting ZBTB45P2 may provide new insights into the pathogenesis and potential therapeutic approaches for various diseases. One of the most significant potential therapeutic applications of ZBTB45P2 is its potential as a cancer therapeutic. ZBTB45P2 has been shown to be involved in the regulation of cell cycle progression, which is a critical process that is involved in the development and progression of cancer. Therefore, targeting ZBTB45P2 may provide new insights into the development and progression of cancer.

In addition to its potential as a cancer therapeutic, ZBTB45P2 may also be a potential therapeutic for neurodegenerative diseases. This gene has been shown to be involved in the regulation of various cellular processes, including cell adhesion and migration. Therefore, targeting ZBTB45P2 may provide new insights into the pathogenesis and potential therapeutic approaches for neurodegenerative diseases.

Another potential therapeutic application of ZBTB45P2 is its potential as an anti-inflammatory therapeutic. This gene has been shown to be involved in

Protein Name: Zinc Finger And BTB Domain Containing 45 Pseudogene 2

The "ZBTB45P2 Target / Biomarker Review Report" is a customizable review of hundreds up to thousends of related scientific research literature by AI technology, covering specific information about ZBTB45P2 comprehensively, including but not limited to:
•   general information;
•   protein structure and compound binding;
•   protein biological mechanisms;
•   its importance;
•   the target screening and validation;
•   expression level;
•   disease relevance;
•   drug resistance;
•   related combination drugs;
•   pharmacochemistry experiments;
•   related patent analysis;
•   advantages and risks of development, etc.
The report is helpful for project application, drug molecule design, research progress updates, publication of research papers, patent applications, etc. If you are interested to get a full version of this report, please feel free to contact us at BD@silexon.ai

More Common Targets

ZBTB46 | ZBTB46-AS1 | ZBTB47 | ZBTB48 | ZBTB49 | ZBTB5 | ZBTB6 | ZBTB7A | ZBTB7B | ZBTB7C | ZBTB7C-AS2 | ZBTB8A | ZBTB8B | ZBTB8OS | ZBTB8OSP1 | ZBTB9 | ZC2HC1A | ZC2HC1B | ZC2HC1C | ZC3H10 | ZC3H11A | ZC3H11B | ZC3H11C | ZC3H12A | ZC3H12A-DT | ZC3H12B | ZC3H12C | ZC3H12D | ZC3H13 | ZC3H14 | ZC3H15 | ZC3H18 | ZC3H18-AS1 | ZC3H3 | ZC3H4 | ZC3H6 | ZC3H7A | ZC3H7B | ZC3H8 | ZC3HAV1 | ZC3HAV1L | ZC3HC1 | ZC4H2 | ZCCHC10 | ZCCHC12 | ZCCHC13 | ZCCHC14 | ZCCHC14-DT | ZCCHC17 | ZCCHC18 | ZCCHC2 | ZCCHC24 | ZCCHC3 | ZCCHC4 | ZCCHC7 | ZCCHC8 | ZCCHC9 | ZCRB1 | ZCWPW1 | ZCWPW2 | ZDBF2 | ZDHHC1 | ZDHHC11 | ZDHHC11B | ZDHHC12 | ZDHHC12-DT | ZDHHC13 | ZDHHC14 | ZDHHC15 | ZDHHC16 | ZDHHC17 | ZDHHC18 | ZDHHC19 | ZDHHC2 | ZDHHC20 | ZDHHC20P1 | ZDHHC20P2 | ZDHHC21 | ZDHHC22 | ZDHHC23 | ZDHHC24 | ZDHHC3 | ZDHHC4 | ZDHHC5 | ZDHHC6 | ZDHHC7 | ZDHHC8 | ZDHHC8BP | ZDHHC9 | ZEB1 | ZEB1-AS1 | ZEB2 | ZEB2-AS1 | ZER1 | ZFAND1 | ZFAND2A | ZFAND2B | ZFAND3 | ZFAND4 | ZFAND5